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Dual screen-printed carbon electrodes modiﬁed with 4-carboxyphenyl-functionalized double-walled
carbon nanotubes (HOOC-Phe-DWCNTs/SPCEs) have been used as scaffolds for the preparation of elec-
trochemical immunosensors for the simultaneous determination of the cytokines Interleukin-1b (IL-1b)
and factor necrosis tumor a (TNF-a). IL-1b. Capture antibodies were immobilized onto HOOC-Phe-
DWCNTs/SPCEs in an oriented form making using the commercial polymeric coating Mix&Go™. Sand-
wich type immunoassays with amperometric signal ampliﬁcation through the use of poly-HRP-
streptavidin conjugates and H2O2 as HRP substrate and hydroquinone as redox mediator were imple-
mented. Upon optimization of the experimental variables affecting the immunosensor performance, the
dual immunosensor allows ranges of linearity extending between 0.5 and 100 pg/mL and from 1 to
200 pg/mL for IL-1b and TNF-a, respectively, these ranges being adequate for the determination of the
cytokines in clinical samples. The achieved limits of detection were 0.38 pg/mL (IL-1b) and 0.85 pg/mL
(TNF-a). In addition, the dual immunosensor exhibits excellent reproducibility of the measurements,
storage stability of the anti-IL-Phe-DWCNTs/SPCE and anti-TNF-Phe-DWCNTs/SPCE conjugates, and
selectivity as well as negligible cross-talking. The dual immunosensor was applied to the simultaneous
determination of IL-1b and TNF-a in human serum spiked at clinically relevant concentration levels and
in real saliva samples.
© 2016 Published by Elsevier B.V.~no).
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Cytokine detection is important for prognosis and diagnosis of
different diseases related with inﬂammation, immunology,
atherosclerosis and cancer [1]. However, monitoring of these pro-
teins show some challenges related to their low concentration
ranges in biological samples [2], which makes it difﬁcult obtaining
accurate and reliable analytical results. Moreover, as cytokines are
known towork in concert to operate on the network of effectors [1]
efﬁcient analytical strategies should be implemented in the form of
multiplexed detection [3]. It is well known that multianalyte ap-
proaches provide more information for each single sample and lead
to faster and low-cost assays.
In this paper, we report the construction and analytical perfor-
mance of an electrochemical platform for the simultaneous
detection of two important cytokines: Interleukin-1b (IL-1b) and
factor necrosis tumor a (TNF-a). IL-1b is a pro-inﬂammatory cyto-
kine produced by a variety of cells including pancreatic cells, adi-
pocytes or macrophages. Similar to other cytokines, the
determination of IL-1b is relevant for monitoring inﬂammatory and
immune processes, but it is also signiﬁcant in some speciﬁc cases.
For instance, elevation of the IL-1b concentration is a typical reac-
tion of the brain to acute injury and it can be found in a number of
chronic neurodegenerative diseases such as Alzheimer [4]. In
addition, high glucose concentrations induce the pancreatic
expression of IL-1b leading to alteration of insulin secretion, as well
as a decrease in cellular proliferation and apoptosis of pancreatic
beta cells. On the other hand, the role of TNF-a is critical in many
diseases including rheumatoid arthritis [5] or cancer [6].
Biological activities of IL-1b and TNF-a, have been reported to be
synergistic and overlapping [7]. For instance, both proteins exert an
important inhibitory function on erythropoiesis blunting theTable 1
Electrochemical immunosensors reported in the literature for the determination of IL-1b
Biomarker Immunosensor Tec
TNFa SiO2-PGMA-QDs-anti-TNF- TNFa -anti-TNF-poly(o-ABA)/AuE SW
TNFa AuNPs/PSA-AP-anti-TNF-TNFa-anti-TNF/PANI/PAA/GCE DPV
TNFa PB-CeO2-anti-TNF-TNFa-anti-TNF-AuNPs/CNTs/GCE amp
TNFa AP/PS-anti-TNF-TNFa-anti-TNF-AuNPs/hydrogel þ Chit/GCE SW
TNFa GOx/GNR-anti-TNF-TNFa-anti-TNF-AuNPs/Fc-FF/PDDA/GCE SW
TNFa TNFa-anti-TNF-poly(o-ABA)/SPCE EIS
TNFa HRP-anti-TNF-TNFa-anti-TNF-poly(o-ABA)/SPCE DPV
TNFa, IL-12 Ab-16-MHDA-AuNPs/AuE EIS
TNFa AP-Strept-Biotin-anti-TNF-TNFa-anti-TNF-MBs-Prot G/SPCE DPV
TNFa TNFa-anti-TNF-PGMA-PFMMA-AuE CV
TNFa TNFa-anti-TNF-Naﬁon/K-Chit-GA/GCE CV
TNFa TNFa -anti-TNF-DSP-Au micro-array EIS
IL-1, IL-6, IL-10 Ab-Au mcroelectrode (BioMEMS). EIS
TNFa HRP-Strept-Biotin-anti-TNF-TNFa-anti-TNF-MBs-COOH/SPCE amp
TNFa TNFa-anti-TNF-MBs-COOH/CSGM EIS
TNFa TNFa-anti-TNF-Ag@Pt/
MWCNTs/Chit/SPCE
DPV
TNFa anti-TNF/IL/C60-MWCNTs/SPCE DPV
TNFa AP-Strept-Biotin-anti-TNF-TNFa-anti-TNF-poly(p-ABA)-SPCE DPV
TNFa, IL-6,
IL-1b, CRP
HRP-MBs-Ab1- Ag -Ab2-GSH-AuNPs/PDDA/SPCE
(microﬂuidic array)
amp
TNFa AP-IgG-anti-TNF-TNFa-anti-TNF (afﬁbody®) -MBs-COOH/SPCE DPV
IL-1b
TNFa,
poly-HRP-Strept-Biotin-anti-TNF-TNFa-anti-TNF-HOOC-Phe-
DWCNTs/SPCE
amp
Ab, antibody; AuE, gold electrode; AP, alkaline phosphatase; AuNPs, gold nanoparticles; C
array; DPV, differential pulse voltammetry; DSP, dithiobis-succinimidylpropionate; EIS,
glassy carbon electrode; GA, glutaraldehyde; GNR, gold nanorod; GOx, glucose oxidase; IL
beads; 16-MHDA,16-mercaptohexadecanoic acid; o-ABA, ortho-aminobenzoic acid; p-AB
Blue; PDDA, polydiallyldimethylammonium; PFMMA, polyferrocenemethylmethacrylate
acrylic acid); QDs, quantum dots; SPCE, screen-printed carbon electrode; SWV, square w
a Counted once the antibody was immobilized.
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nanotubes, Analytica Chimica Acta (2017), http://dx.doi.org/10.1016/j.acaendogenous production of EPO, and might play a role in the path-
ogenesis of anemia of chronic disorders or that of cancer patients
which respond to recombinant EPO [8]. Moreover, increased IL-1b
and TNF-a levels in vitreous humor and serum of patients with
proliferative diabetic retinopathy has also been described [9].
Elevated levels of various cytokines, including IL-1b and TNF-a,
have also been identiﬁed in the circulation of traumatic brain injury
(TBI) patients within hours of injury [10]. Interestingly, both pro-
teins can be used as biomarkers to predict side effects of cancer
therapy such as inﬂammatory oral mucositis [11]. In addition,
determination of salivary contents of both cytokines in patients
with leukoplakia and oral cancer has a great interest [12] and very
recently they have also been considered as novel biomarkers for the
detection of periodontal diseases [13].
Due to the normal levels of IL-1b and TNF-a in biological ﬂuids
are in the concentration range of few pg/mL, sufﬁcient sensitivity is
a requirement for the developed analytical methods. Therefore,
enhancement in sensitivity has been a common issue for the pre-
viously reported electrochemical immunosensors. As Table 1 shows
[14e30], the number of sensors described for TNF-a is relatively
high whereas those for IL-b1 are very scarce. Diverse electrode
modiﬁers [15,16], signal ampliﬁers [16,17] and a variety of electro-
chemical techniques [18,19] have been employed to attain the
required detection limits. Regarding the simultaneous determina-
tion of these cytokines, only three electrochemical immunoassay
conﬁgurations have been reported (Table 1). An ultrasensitive
microﬂuidic array was developed for TNF-a, IL-6, IL-1b, and C-
reactive protein to assess oral mucositis risk in cancer patients.
Magnetic beads were used to capture the analytes from serum and
detected with a sensor array coated with gold nanoparticles and
antibodies [11]. A fully integrated BioMEMS was also developed to
simultaneously detect various interleukins (IL-1, IL-10, and IL-6) [3].and TNF-a
hnique L.R., pg/mL LOD,
pg/mL
Assay timea Sample Ref.
V 10e106 3 90 min e [14]
20e20000 10 2 h 50 min Spiked serum [15]
erom. 5e5000 2 2 h 30 min Spiked serum [16]
V 1e10000 0.5 2 h 30 min Spiked serum [17]
V 5e10000 5 2 h 30 min Spiked serum [18]
up to 100 5 2 h Spiked serum [19]
up to 50 3.2 3 h Spiked serum [19]
e 60; 3.4 30 min e [20]
up to 5000 44 2 h 40 min Spiked serum [21]
1e106 3.9 2 h 30 min e [22]
20e34000 10 60 min þ
blocking
Spiked serum [23]
1e10 1 1 h 15 min Cell culture [24]
1e15 e e e [3]
erom. 5 - 5  106 2 3 h 10 min Spiked serum [25]
1e1000 1 1 h 25 min Spiked serum [26]
6e60 1.6 >8 h Spiked serum [27]
5e75 2 >8 h Spiked serum [34]
3250e50000 4100 3 h 10 min Spiked serum [29]
erom. 0.04e22 (IL)
0.01e12 (TNF)
0.04 (IL)
0.01 (TNF)
2 h 22 min Spiked and
real serum
[11]
76e5000 38 3 h 30 min Spiked serum [30]
erom. 0.5e100 (IL)
1 - 200 (TNF)
0.38 (IL)
0.85 (TNF)
2 h 30 min Spiked serum,
saliva
This work
hit, chitosan; CNTs, carbon nanotubes; CSGM, comb structured gold microelectrode
electrochemical impedance spectroscopy; Fc, ferrocene; FF, diphenylalanine; GCE,
-12, interleukin-12; K-Chit-GA, K3[Fe(CN)6]-chitosan-glutaraldehyde; MBs, magnetic
A,para-aminobenzoic acid; PAA, poly(acrylic acid); PANI, polyaniline; PB, Prussian
; PGMA, polyglycidylmethacrylate; PS, polyethylene sphere; PSA, poly(styrene-co-
ave voltammetry.
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mine TNF-a and IL-12 with limits of detection of 60 and 3.4 pg/mL,
respectively, by conjugation of antibodies to gold nanoparticles
through self-assembled monolayers of 16-mercaptohexadecanoic
acid [20]. It is worth to mention that commercial ELISA kits for
the single determination of IL-1b or TNF-a are available but they are
characterized by the long assay times required and the relatively
large sample volumes.
The immunosensor described in this work for the simultaneous
determination of IL-b1 and TNF-a involves the use of dual screen-
printed carbon electrodes (SPCEs) modiﬁed with 4-
carboxyphenyl-functionalized double-walled carbon nanotubes
(HOOC-Phe-DWCNTs) as electrochemical scaffolds for immobili-
zation of the speciﬁc anti-IL-1b and anti-TNF-a antibodies. As it is
known, DWCNTs possess several beneﬁcial properties with respect
to MWCNTs for the preparation of electrochemical biosensors such
as improved lifetimes and high stability under chemical, mechan-
ical and thermal treatments [31]. Moreover, DWCNTs provide better
electrochemical behavior than SWCNTs enhancing electron transfer
and allowing signiﬁcant overpotential reduction for various spe-
cies. Furthermore, they show a higher reactivity, probably as a
consequence of the larger number of lattice defects in DWCNTs
[32]. Furthermore, upon chemical modiﬁcation of DWCNTs, the
outer cylinder acts as a protective sheath that preserves the elec-
tronic properties of the inner tube. Therefore, covalent sidewall
chemistry can be performed onto DWCNTs without loss of the
intrinsic properties [33].
Capture antibodies were immobilized onto HOOC-Phe-
DWCNTs/SPCEs in an oriented form making using the commercial
polymeric coating Mix&Go™. This polymer contains several
metallic complexes with a high efﬁciency to bind proteins [34].
Sandwich type immunoassays with signal ampliﬁcation through
the use of poly-HRP-streptavidin conjugates were performed for
each cytokine. This simple and relatively low cost immunosensor
conﬁguration allowed the development of a sensitive method for
the simultaneous determination of IL-b1 and TNF-a exhibiting
improved overall analytical performance with respect to previously
reported data. In addition and in order to demonstrate the
analytical usefulness of the developed methodology, the dual
immunosensor was applied to the determination of both proteins
in human serum and saliva.
2. Experimental
2.1. Reagents and solutions
Mouse TNFa capture antibody (anti-TNF), biotinylated goat
TNFa detection antibody (biotineantieTNF), mouse IL1b capture
antibody (anti-IL), and biotinylated goat ILb1 detection antibody
(biotin-anti-IL) were used. These immunoreagents as well as hu-
man TNFa and ILb1 proteins were those included in the DuoSet®
ELISA Development Systems DY201-05 (ILb1), and DY210e05
(TNFa) from R&D Systems. Solutions of the respective capture an-
tibodies at a concentration level of 240 mg/mL were prepared by
dissolving the product in 500 mL PBS. Working solutions were
prepared by dilution into a 25 mM buffer solution of
2e(Nemorpholino) ethanesulfonic acid (MES, Gerbu) of pH 5.0.
Solutions of the respective detection antibodies at 18 mg/mL (TNFa)
or 12 mg/mL (ILb1) concentrations were prepared by dissolving the
product in 1 mL PBS and 1% BSA. Phosphate buffer saline solution
(PBS) consisted of a 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4,
and 1.5 mM KH2PO4 solution of pH 7.4.
Streptavidin labeled with horseradish peroxidase (HRP-Strept,
Roche), poly-HRP-Strept (85-R200) conjugate (Fitzerald), poly-
HRPeStrept (S2438) conjugate (Sigma), and HRPeStrepteAuNPsPlease cite this article in press as: E. Sanchez-Tirado, et al., Electrochemical
and tumor necrosis factor alpha in serum and saliva using dual screen pri
nanotubes, Analytica Chimica Acta (2017), http://dx.doi.org/10.1016/j.aca(Nanovex Biotechnologies) were tested. Solutions from each con-
jugate at the working concentration were prepared in PBS. Double-
walled carbon nanotubes functionalizedwith peaminobenzoic acid
(HOOC-Phe-DWCNTs) were provided by Instituto de Nanociencia,
Nanotecnología y Materiales Moleculares (INAMOL) de la Uni-
versidad de Castilla La Mancha (Toledo), Mix&Go™ polymer was
from Anteo Diagnostics. Hydroquinone (HQ) and hydrogen
peroxide (30%, w/v) were from Sigma. Bovine serum albumin (BSA)
was from GERBU Biotechnik, GmbH. Blocker® Casein in PBS was
from Thermo Fisher. Adiponectin (APN, Abcam), ceruloplasmin (Cp,
Abcam), ghrelin (GHRL, Anaspec) bovine serum albumin (BSA,
Gerbu), cholesterol (Chol, Sigma), transforming growth factor b1
(TGF b1, R&D Systems), hemoglobin (Hb, Sigma), C-reactive protein
(CRP, Fitzgerald), interleukin 6 (IL-6, Abcam), interleukin 8 (IL-8,
Abcam), bilirubin (BIL, Aldrich), and leptin (Lep, R&D Systems)
were tested as potential interfering compounds. Deionized water
was from a Millipore Milli-Q puriﬁcation system (18.2MU cm at
25 C).
2.2. Apparatus and electrodes
All electrochemical measurements were carried out with a
potenciostat from INBEA Biosensores S.L. equipped with the
IbGraph software. Screen-printed carbon electrodes (SPCEs, 110
DRP, f 4 mm), and dual SPCEs (C 1110 DRP) consisted of two elliptic
carbonworking electrodes with surface area of 5.6 mm2, were from
DropSens (Oviedo, Spain). These electrodes include a carbon
counter electrode and a silver pseudo-reference electrode. An
Elmasonic Se60 (Elma) ultrasonic bath, a Gyrozen 416 centrifuge
(Controltechnica Instruments), and a Vortex homogenizator (Velp
Scientiﬁca) were also used. pH measurements were performed
using a Crison Basic 20þ pHemeter. All experiments were per-
formed at room temperature.
2.3. Samples
The samples analyzed were lyophilized human serum (S2257,
Sigma) spiked with 2.5, 5 and 7.5 pg/mL IL-1b and 5, 10 and 15 pg/
mL TNF-a, and saliva samples obtained from two lab researcher
(male smoker and female nonsmoker volunteers) and collected
using a Salivette® collection device (Sarstedt).
2.4. Procedures
2.4.1. Preparation of the immunosensors
A homogeneous dispersion of HOOCePheeDWCNTs was pre-
pared by suspending 1 mg of the product in 2 mL distilled water,
addition of 27.4 mL of Tween® 20, and ultrasonic stirring for 60 min.
Thereafter, modiﬁcation of the electrodes was made by casting
0.5 mL of the HOOCePheeDWCNTs dispersion onto the electrode
surface and allowing drying under IR radiation. This procedure was
repeated until a total dispersion volume of 1.5 mL was deposited.
Next, 2.5 mL of Mix&Go solution were added and incubated for
60 min. Thereafter, the modiﬁed electrode was rinsed with water
and allowed drying. This washing was accomplished after each
electrode modiﬁcation once incubation was made. Then, the cor-
responding capture antibody (antieIL or anti-TNF) was immobi-
lized by casting 2.5 mL of 4 mg/mL solution of each antibody and
incubating for 60 min. Blocking with 2.5 mL of a 2% BSA solution in
PBS for 30 min was then made to minimize unspeciﬁc interactions.
Thereafter, 2.5 mL of the antigen (IL-b1 and/or TNF-a) standard
solution or the sample were added and incubated for 60 min. Next,
2.5 mL of 0.5 mg/mL biotinylated antibody solution (BiotineantieIL
or Biotin-anti-TNF) were added and incubated for 45 min. Finally,
2.5 mL of a 1/500 diluted polyeHRPeStrept solution were droppedimmunosensor for simultaneous determination of interleukin-1 beta
nted electrodes modiﬁed with functionalized doubleewalled carbon
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2.4.2. Simultaneous determination of IL-b1 and TNF-a
The determination of both cytokines was accomplished by
dropping 45 mL of a 1 mM HQ solution onto the surfaces of the dual
SPCE immunosensor horizontally positioned and applying a
detection potential of 0.20 V. Once the background current was
stabilized (approx.100 s), 5 mL of a 50mMH2O2 solutionwas added
and allowed standing for 200 s. The steady state current corre-
sponding to the electrochemical reduction of benzoquinone was
used as the analytical readout.
2.4.3. Samples analysis
Lyophilized serum was ﬁrstly reconstituted by dissolving
370 mg in 5 mL of deionized water mixing with gentle stirring.
Then, the serumwas spiked with 2.5, 5 or 7.5 pg/mL IL-1b and 5, 10
or 15 pg/mL TNF-a, and the determination of both proteins was
performed by application of the procedures 2.4.1 and 2.4.2. and
interpolation of the amperometric responses in the respective
calibration plot constructed with standard solutions.
Regarding saliva, samples were collected from the volunteers
after rinsing the mouth thoroughly with water and chewing a
cotton swab for 5 min. Then, the swap saturated with saliva was
inserted into a vial, sealed with the cap and centrifuged for
10min at 3000 g. The determinationwas performed immediately
by applying the procedure described above using 5-mL aliquots of
the undiluted sample.
3. Results and discussion
The methodologies employed in this work involved the immo-
bilization of capture antibodies onto SPCEs modiﬁed with 4-
carboxyphenyl-functionalized double-walled carbon nanotubes
(HOOC-Phe-DWCNTs) and application of sandwich type immuno-
assays for each cytokine with signal ampliﬁcation through the useFig. 1. Schematic display of the different steps involved in the preparation of the dual electr
Please cite this article in press as: E. Sanchez-Tirado, et al., Electrochemica
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nanotubes, Analytica Chimica Acta (2017), http://dx.doi.org/10.1016/j.acaof poly-HRP-streptavidin conjugates. These strategies took advan-
tage of: i) the well-known enhancement of electron transfer pro-
cesses occurring on DWCNTs-modiﬁed electrode surfaces, ii) the
high availability of surface conﬁned carboxyl groups onto HOOC-
Phe-DWCNTs, iii) the oriented immobilization of antibodies by
means of Mix&Go polymer, and iv) the ampliﬁcation of the elec-
trochemical responses with poly-HRP-Strept.
The protocols used for the preparation of the dual immuno-
sensor are described in the Experimental section and schematically
displayed in Fig. 1. Once Mix&Go was dropped onto each surface of
HOOC-Phe-DWCNTs-modiﬁed dual SPCE, anti-IL and anti-TNF an-
tibodies were immobilized and a subsequent blocking step of the
remaining active free sites on the electrode surfaces was carried
out. Then, sandwich type assays involving the target cytokines and
biotinylated detector antibodies were accomplished. A further
conjugation with poly-HRP-Strept allowed the amperometric
determination of IL-1b and TNF-a to be performed using H2O2 as
HRP substrate and hydroquinone (HQ) as the redox mediator.3.1. Optimization of the experimental variables involved in the
preparation of the dual immunosensor
Variables involved in the preparation of the dual immunosensor
for the simultaneous determination of IL-1b and TNF-a were opti-
mized. These studies were performed individually for each cyto-
kine using single modiﬁed-SPCEs and included: a) the antibody
(anti-IL or anti-TNF) loading onto HOOC-Phe-DWCNTs/SPCE and
the time for incubation; b) the Biotin-antibody loading onto IL-1b-
anti-IL-Phe-DWCNTs/SPCE or TNF-a-anti-TNF-Phe-DWCNTs/SPCE
and the time for incubation; c) the blocking step, and d) the type of
enzyme label and the loading of poly-HRP-Strept onto Biotin-anti-
IL-IL1b-anti-IL-Phe-DWCNTs/SPCE or Biotin-anti-TNF-TNF-a-anti-
TNF-Phe-DWCNTs/SPCE. Other variables involved in the prepara-
tion of the modiﬁed electrodes such as the loading of HOOC-Phe-
DWCNTs onto SPCE and the loading of Mix&Go onto HOOC-Phe-ochemical immunosensor for multiplexed determination of IL-1b and TNF-a cytokines.
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detection such as the detection potential value or the concentration
of H2O2 and HQ were the same than those employed in previous
papers [35,36]. Details on these optimization studies are provided
in Supplementary material and Figs. S1-S4 and summarized in
Table 2.3.2. Analytical characteristics of the dual immunosensor
The calibration plots for IL-1b and TNF-a constructed with the
dual immunosensor under the optimized working conditions are
shown in Fig. 2. Error bars were calculated from the measurements
carried out with three different dual immunosensors for each
concentration. The steady state current vs. IL-1b concentration
(Fig. 2a) followed the adjusted equation I, nA¼ (624 ± 15) log C, pg/
mL þ 393 ± 18 (r2 ¼ 0.996), with a range of linearity extending
between 0.5 and 100 pg/mL IL-1b. Fig. 2b displays the calibration
plot for TNF-a with an equation I, nA ¼ (746 ± 16) log C, pg/
mL þ (245 ± 22) (r2 ¼ 0.999), with a range of linearity from 1 to
200 pg/mL. It is worth to mention that these ranges, covering two
orders of magnitude, are adequate for the determination of the
cytokines in clinical samples taking into account the expected
concentrations at the level of few pg/mL [19]. The achieved limits of
detection were 0.38 pg/mL (IL-1b) and 0.85 pg/mL (TNF-a) and
were calculated by using the 3sb criterion, where sb was estimated
as the standard deviation expressed in concentration units (n ¼ 10)
of the measured currents for the blank (0 pg/mL IL-1b or TNF-a).
When these analytical characteristics are compared with those
reported for other electrochemical immunosensors (Table 1), it can
be concluded that the developed methodology can be ranked
among themost sensitive exhibiting low detection limits and linear
ranges covering low concentration ranges. It should also be
remarked that this excellent analytical performance is accompa-
nied by a relatively short time of analysis. In fact, the whole
experimental procedure, once the capture antibodies are immobi-
lized, took 2 h 30 min. This period is much shorter than that
required when commercial ELISA kits for IL-1b or TNF-a are
employed. For example, the assays with the DuoSet® ELISA from
R&D Systems [www.rndsystems.com] last 4 h 40 min.
The reproducibility of the measurements was tested with
different dual immunosensors prepared on the same day and on
different days, and in the absence or in the presence of 50 pg/mL IL-
1b or 100 pg/mL TNF-a. The relative standard deviation (RSD)
values obtained were 0.6 and 2.7% (IL-1b) (n ¼ 4), and 0.3 and 0.7%Table 2
Optimization of the experimental variables affecting the performance of poly-HRP-
Strept-Biotin-anti-IL-IL-1b-anti-IL-Phe-DWCNTs/SPCE and poly-HRP-Strept-Biotin-
anti-TNF-TNF-a-anti-TNF-Phe-DWCNTs/SPCE immunosensors.
Variable Tested Selected
Capture antibody (Ab), mg/mL 2-8 (IL-1b);
1-5 (TNF-a)
6 (IL-1b);
4 (TNF-a)
Incubation time for Ab, min 30-90 (IL-1b);
30-60 (TNF-a)
60
Biotinylated antibody
(Biotin-Ab), mg/mL
0.25e1 (IL-1b);
0.25e0.75 (TNF-a)
0.5
Incubation time for Biotin-Ab),
min
30e90 60
Blocking agent type 1%BSA, 2%BSA,
casein, milk powder
2% BSA
HRP- Strept label type HRP-Strept, HRP-Strept-AuNPs,
poly-HRP-Strept (F),
poly-HRP-Strept (S)
poly-HRP-
Strept (F),
poly-HRP-Strept,
dilution
1/500 - 1/1000 (IL-b1)
1/250 - 1/2000 (TNF-a)
1/500
(F) Fitzgeral; (S) Sigma.
Please cite this article in press as: E. Sanchez-Tirado, et al., Electrochemical
and tumor necrosis factor alpha in serum and saliva using dual screen pri
nanotubes, Analytica Chimica Acta (2017), http://dx.doi.org/10.1016/j.aca(TNF-a) (n ¼ 5), respectively, for the assays performed on the same
day, and 0.8% and 3.7% (IL-1b) (n ¼ 4), and 0.5 and 0.7% (TNF-a)
(n ¼ 5) respectively, for the measurements made on different days.
These results indicated the good level of precision achieved in the
fabrication and functioning of the developed dual electrochemical
immunosensing platform.
In addition, the storage stability of the anti-IL-Phe-DWCNTs/
SPCE and anti-TNF-Phe-DWCNTs/SPCE conjugates, once they were
blocked with 2% BSA, was tested under storage at 20 C in a dry
environment. Several bioconjugates were prepared on the same
day, stored, and used to construct on different days, poly-HRP-
Strept - Biotin - anti - IL - IL1b - anti - IL - Phe - DWCNTs/SPCE
and poly - HRP-Strept-Biotin-anti-TNF-TNF-a-anti-TNF-Phe-
DWCNTs/SPCE dual immunosensors. The amperometric currents
measured for 50 pg/mL IL-1b and 100 pg/mL TNF-a solutions
(Fig. S5) remained within the control limits set by ± 3 times the
standard deviation of the measurements (n ¼ 3) carried out on the
ﬁrst day, during at least 40 days. This excellent storage stability
suggests the possibility of preparing a set of anti-IL-Phe-DWCNTs/
SPCE and anti-TNF-Phe-DWCNTs/SPCE conjugates and storing
them under the above mentioned conditions until their use for the
preparation of the immunosensors was requested.
3.3. Selectivity studies
The effect of potential interfering compounds that may be pre-
sent together with the target cytokines in biological samples on the
electrochemical responses obtained with the dual immunosensors
was studied. As the used antibodies exhibit demonstrated speci-
ﬁcity for IL-1b or TNF-a against other cytokines such as IL-1a, or
TNF-b, TNF-RI and TNF-TII, respectively, the compounds tested
were: adiponectin (APN), bovine serum albumin (BSA), cholesterol
(Chol), C-reactive protein (CRP), hemoglobin (Hb), interleukin 6 (IL-
6), interleukin-8 (IL-8), transforming growth factor b1 (TGF-b1),
bilirubin (BIL), ceruloplasmin (Cp), ghrelin (GHRL) and leptin (LEP).
Fig. 3 shows a comparison of the amperometric responses obtained
with the dual immunosensor for 0 and 10 pg/mL IL-1b or TNF-a in
absence and in the presence of each tested compound at their
normal concentration levels in human serum. As it is clearly shows,
no signiﬁcant effect on the dual electrochemical immunosensor
response was apparent in the presence of any non-target com-
pound, thus demonstrating the excellent selectivity of the pro-
posed conﬁguration for simultaneous IL-1b and TNF-a
determination.
Moreover, the possible cross-talking between the adjacent
working modiﬁed SPCEs in the dual conﬁguration and reaction
products was evaluated by comparing the amperometric responses
recorded at the poly-HRP-Strept-Biotin-anti-IL-IL1b-anti-IL-Phe-
DWCNTs/SPCE where 10 pg/mL TNF-a were deposited, and at the
poly-HRP-Strept-Biotin-anti-TNF-TNF-a-anti-TNF-Phe-DWCNTs/
SPCEwith 25 pg/mL IL-1b, with those obtained for 0 or 25 pg/mL IL-
b1 and 10 pg/mL TNF-a, respectively. Fig. 4 shows clearly that no
signiﬁcant differences in the amperometric responses of immu-
nosensors exist in the absence of the non-target antigen, thus
demonstrating that no appreciable cross-talking occurred with the
developed dual immunosensor.
3.4. Simultaneous determination of IL-1b and TNF-a in spiked
serum and saliva
The developed dual immunosensor was applied to the simul-
taneous determination of IL-1b and TGF-b in human serum spiked
at clinically relevant concentration levels [37,38] and in real saliva
samples. Regarding serum, the possible existence of matrix effects
was initially evaluated by constructing a calibration plot in theimmunosensor for simultaneous determination of interleukin-1 beta
nted electrodes modiﬁed with functionalized doubleewalled carbon
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Fig. 2. Calibration plots for IL-1b (green) and TNF-a (blue) obtained with the dual poly-HRP-Strept-Biotin-anti-IL-IL1b-anti-IL-Phe-DWCNTs/SPCE and poly-HRP-Strept-Biotin-anti-
TNF-TNF-a-anti-TNF-Phe-DWCNTs/SPCE immunosensor. See text for other conditions. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to
the web version of this article.)
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Fig. 3. Effect of the presence of 20 mg/mL APN, 5 mg/mL BSA, 190 ng/mL bilirubin (BIL), 20 mg/mL Chol, 500 mg/mL ceruloplasmin (Cp), 500 pg/mL ghrelin (GHRL), 50 mg/mL Hb,
50 pg/mL IL-6, 30 pg/mL ILe8, 5 ng/mL leptin (Lep), 500 pg/mL TGFeb1, 100 pg/mL TNFea (a) or 50 pg/mL ILe1b (b), 1 mg/mL CRP on the amperometric responses obtained for
0 (white) and 10 (grey) pg/mL IL-1b (a) or TNF-a (b) at the dual electrochemical immunosensor. See the text for more information.
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1b over the 2.5e7.5 pg/mL, and with TNF-a over the 5e15 pg/mL
concentration ranges, respectively. The equations obtained for the
respective calibration graphs were I, nA ¼ (597 ± 6) log C, pg/
mL þ (400 ± 4), (r2 ¼ 0.9998), and I, nA¼ (766.3 ± 0.2) logC, pg/
mL þ (237.8 ± 0.2), (r2 ¼ 0.9999) for IL-1b and TNF-a, respectively.
The comparison of the slope values with those calculated for the
calibration plots constructed with standard solutions by applying
the Student's t-test showed texp values 1.655 (IL-1b) and 1.231 (TNF-
a) lower than that tabulated t, 2.306, therefore indicating that noPlease cite this article in press as: E. Sanchez-Tirado, et al., Electrochemica
and tumor necrosis factor alpha in serum and saliva using dual screen pr
nanotubes, Analytica Chimica Acta (2017), http://dx.doi.org/10.1016/j.acastatistically signiﬁcant differences existed between the slopes
values for both types of calibration plots. Therefore, the determi-
nation of IL-1b and TNF-a could be carried out by interpolation of
the current values measured for the serum samples into the cali-
bration plots constructed with the standard solutions. Table 3
summarizes the results obtained by triplicate analysis of samples
spiked at three different concentration levels: 2.5, 5.0 and 7.5 pg/
mL IL-1b and 5.10 and 15 pg/mL TNF-a. As it can be seen, recoveries
ranged between 98 and 104%, indicating the reliability of the
approach to determine low IL-1b and TNF-a concentrations inl immunosensor for simultaneous determination of interleukin-1 beta
inted electrodes modiﬁed with functionalized doubleewalled carbon
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Fig. 4. Amperometric responses recorded with the dual immunosensor at poly-HRP-Strept-Biotin-anti-IL-IL1b-anti-IL-Phe-DWCNTs/SPCE for 25 or 0 pg/mL IL-1b (green), or 10 pg/
mL TNF-a (blue) (a), and at poly-HRP-Strept-Biotin-anti-TNF-TNF-a-anti-TNF-Phe-DWCNTs/SPCE for with 10 or 0 pg/mL TNF-a (blue), or 25 pg/mL IL-1b (green) (b). See the text for
more information. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Furthermore, two different saliva samples corresponding to a
male smoker and a female nonsmoker volunteers were analyzed to
determine the endogenous content of both IL-1b and TNF-a.
Considering the complexity of saliva, we also evaluated the po-
tential occurrence of matrix effect. A calibration plot was con-
structed by adding known cytokine concentrations between 0.5
and 50 pg/mL for IL-1b and 2 and 40 pg/mL for TNF-a to saliva from
both patients. The respective slope values of the linear ranges
(630 ± 14 and 627 ± 5 for IL-1b; 745 ± 37 and 758 ± 5 for TNF-a)
were statistically compared with those calculated from the cali-
bration graphs with IL-1b or TNF-a standards. (624 ± 15 and
746 ± 16 nA per decade of concentration). No signiﬁcant difference
for a 95% conﬁdence interval (texp ¼ 0.27 and 0.17 (IL-1b) and 0.10
and 0.67 (TNF-a) were lower than ttab ¼ 2.201). Accordingly, the
determination of IL-1b and TNF-a in saliva was accomplished byTable 3
Simultaneous determination of IL-1b and TNF-a in spiked serum with the dual
immunosensor.
IL-1b, pg/mL IL-1b founda, pg/mL Recovery, %
2.5 2.5 ± 0.2 99 ± 8
5.0 4.9 ± 0.4 98 ± 6
7.5 7.3 ± 0.5 98 ± 8
TNF-a, pg/mL TNF-a founda, pg/mL Recovery, %
5 5.1 ± 0.2 102 ± 7
10 10.2 ± 0.6 102 ± 5
15 15.7 ± 0.9 104 ± 6
a Mean value ± ts/√n.
Table 4
Simultaneous determination of IL-1b and TNF-a in saliva with the dual
immunosensor.
Immunosensor* ELISA**
IL-1b, pg/mL IL-1b, pg/mL
Male smoker 52 ± 1 51.8 ± 0.5
Female nonsmoker 46.5 ± 0.5 46.5 ± 0.4
TNF-a, pg/mL TNF-a, pg/mL
Male smoker 13.3 ± 0.5 13.5 ± 0.9
Female nonsmoker 11.2 ± 0.3 11.3 ± 0.7
Mean value ± ts/√n (*n ¼ 8; **n ¼ 4).
Please cite this article in press as: E. Sanchez-Tirado, et al., Electrochemical
and tumor necrosis factor alpha in serum and saliva using dual screen pri
nanotubes, Analytica Chimica Acta (2017), http://dx.doi.org/10.1016/j.acainterpolation of the measured current in the samples into the
calibration plot constructed with standard solutions. Table 4 sum-
marizes the results obtained in the analysis of saliva. Interestingly,
the found values re consistent with those reported using other
approaches and, as expected, no signiﬁcant differences in salivary
concentrations of the cytokines are apparent between smoker and
non smoker individuals.
In addition, the results were compared with those obtained
using the DuoSet® ELISA Development Systems DY201-05 (IL1b),
and DY210e05 (TNFa) from R&D Systems. The ELISA protocols
were similar for both cytokines and, brieﬂy, involved incubating the
capture antibody solution into the wells overnight at room tem-
perature, followed by washing and blocking with BSA for a mini-
mum of 1 h. Then, 100 mL of the sample or standards per well were
added and incubated 2 h at room temperature. After washing,
100 mL of the detection antibody (biotinylated antibody) were
added to each well and incubated 2 h at room temperature. Once
washed, 100 mL of the HRP-Strept solution were added to each well
leaving for 20 min at room temperature, and color development
was achieved by the addition of TMB substrate solution. Finally,
after 20min, an acid “stop solution”was added, and the absorbance
was measured at 450 nM. As it can be deduced from Table 4, the
results obtained are consistent with those provided by the immu-
nosensor. Indeed, the concentration values found by both methods
were statistically compared by means of the Student's t-test. The
texp values, 0.30 and 0.15 for IL-1b and 0.55 and 0.30 for TNF-a, were
lower than the tabulated t value (2.16) and, therefore, no signiﬁcant
differences were found between both methodologies at a signiﬁ-
cance level of 0.05. These results demonstrate clearly the usefulness
of the developed immunosensor to determine simultaneously IL-1b
and TNF-a at clinically relevant concentrations in biological ﬂuids
such as serum or saliva.4. Conclusions
An electrochemical dual platform for the simultaneous deter-
mination of IL-b1 and TNF-a cytokines is reported in this work. The
platform proﬁts the beneﬁts inherent to electrode modiﬁcation
with 4-carboxyphenyl-functionalized double-walled carbon nano-
tubes where speciﬁc anti-IL-1b and anti-TNF-a antibodies were
immobilized in an oriented manner using the commercial poly-
meric coating Mix&Go™. Sandwich type immunoassays with
signal ampliﬁcation by means of poly-HRP-streptavidin conjugatesimmunosensor for simultaneous determination of interleukin-1 beta
nted electrodes modiﬁed with functionalized doubleewalled carbon
.2016.12.034
E. Sanchez-Tirado et al. / Analytica Chimica Acta xxx (2017) 1e88allowed the development of a sensitive method for the simulta-
neous determination of IL-b1 and TNF-a with improved analytical
performance with respect to previously reported approaches and
commercial ELISA kits. The dual immunosensor was successfully
applied to the determination of both cytokines at clinically relevant
concentrations in biological ﬂuids such as serum or saliva. In this
context, an important point to be remarked is the simultaneous
assay takes about 2 h 30 min once the capture antibodies were
immobilized. Conversely, ELISAs require 4 h 40 min for each
determination. Moreover, the reagents consumption is much lower
in the method using the dual immunosensor since it only requires
2.5 mL each time while 100 mL of the same reagents are needed in
the ELISA protocol.
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S1.1. Effect of the antibodies loading and the time for incubation. 
 The influence of the amount of anti-IL or anti-TNF antibodies immobilized onto 
HOOC-Phe-DWCNTs/SPCEs using Mix&Go polymer was evaluated by checking the 
amperometric responses obtained with different immunosensors for 0 (unspecific) and 
50 pg/mL IL-1β or TNF-α. The immunosensors preparation involved deposition of 5 μL 
of anti-IL or anti-TNF solutions prepared in the 2- 8 μg/mL or 1-5 μg/mL concentration 
range, respectively, and applying the procedure described in sections 2.4.1 and 2.4.2 
with 0.5 μg/mL Biotin-anti-IL or Biotin-anti-TNF  and 5 μg/mL of 1/2000 diluted poly-
HRP-Strept. Figure S1a shows as the measured current values for IL-1β reached a 
maximum value for anti-IL loadings between 4 and 6 µg/mL. Regarding TNF-α,  
current values increased with anti-IL loading up to 4 µg/mL and slightly decreased for 
larger loading. Furthermore, the mentioned concentrations also provided the maximum 
specific to unspecific current ratios. Therefore, 6 µg/mL anti-IL and 4 µg/mL anti-TNF 
were selected for the preparation of the immunosensors. The time elapsed in incubation 
of anti-IL or anti-TNF was also optimized over the 30 to 90 min (IL-1β) and 30 to 60 
(TNF-α) ranges. Results shown in Figure S1b and S1d indicated that an incubation  time 
of 60 min was adequate for the preparation of both immunosensors. 
 
Figure S1. Effect of the antibodies loading (a) and (c) and incubation time (b) and (d) on 
the amperometric responses provided by the immunosensors constructed for the 
determination of  IL-1β and TNF-α. Operational conditions: 3 μL COOH-Phe-
DWCNTs; 5 μL Mix&Go, 60 min;  5 μL anti-IL (a) or anti-TNF (c), 60 min; 5 μL 2% 
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BSA, 30 min; 5 μL 0 pg/mL IL-1β or TNF-α (white), and 50 pg/mL IL-1β or  TNF-α 
(grey), 60 min; 5 μL 0.5 µg/mL  Biotin-anti-IL (a) or  Biotin-anti-TNF (c), 60 min; 5 μL 
1/2000 diluted HRP-Strept, 20 min; 5 µL 6 μg/mL anti-IL (b) or  4  μg/mL anti-TNF 
(d); 5 μL 2% BSA, 30 min; 5 μL  0 pg/mL IL-1β or TNF-α (white), 25  pg/mL IL-1β 
(grey) or 10 μg/mL TNF-α (grey), 60 min; 5 µL 0.5 µg/mL Biotin-anti-IL (c) or  Biotin-
anti-TNF (d), 60 min; 5 μL 1/500 diluted poly-HRP-Strept (b) or 1/1000 diluted poly-
HRP-Strept (d), 15 min. 
 
S1.2. Effect of the biotinylated antibodies loading and the time for incubation. 
 In order to optimize the concentrations of Biotin-anti-IL and Biotin-anti-TNF, 
different immunosensors were prepared by incubating for 60 min IL-1β-anti-IL-Phe-
DWCNTs/SPCE or TNF-α-anti-TNF-Phe-DWCNTs/SPCE, prepared in the absence 
(white) or in the presence of 250 pg/mL (IL-1β) (grey) (a) and in the absence (white) or 
50 pg/mL (TNF-α) (grey) (c), in 0.25-1.0 μg/mL Biotin-anti-IL or 0.25-0.75 μg/mL 
Biotin-anti-TNF solutions. As it can be seen in Figure S2, specific and unspecific 
currents increased slightly for both cytokines in the tested concentration ranges showing 
the largest specific-to-unspecific current ratios at a 0.5 μg/mL concentration of each 
biotinylated antibody, which, accordingly, were selected for further work. Moreover, 
the effect of the incubation time in Biotin-anti-IL (b) or Biotin-anti-TNF (d) solutions 
was also evaluated over the 30 to 90 min interval by testing the amperometric responses 
obtained with the respective immunosensor in the absence of IL-1β or TNF-α (white), 
or in the presence of 25 pg/mL IL-1β  or 10 pg/mL TNF-α (grey). In both cases the 
largest specific-to-unspecific current ratio was obtained at 60 min and, therefore, this 
time was selected as the incubation time in this step.  
 
 Figure S2. Effect of the biotinylated antibodies loading (a) and (c) and the incubation 
time (b) and (d) on the amperometric responses provided by the immunosensors 
constructed for the determination of  IL-1β and TNF-α. 3 μL COOH-Phe-DWCNTs; 5 
μL Mix&Go, 60 min;  5 μL 6 μg/mL anti-IL (a) or 4 μg/mL anti-TNF (c), 60 min; 5 μL 
2% BSA, 30 min; 5 μL 0 pg/mL IL-1β or TNF-α (white), 250 pg/mL IL-1β or 50 pg/mL 
TNF-α (grey), 60 min; 5 μL Biotin-anti-IL (a) or Biotin-anti-TNF (c), 60 min; 5 μL 
1/2000 diluted HRP-Strept, 20 min; 5 µL 6 μg/mL anti-IL (b) or 4  μg/mL anti-TNF (d); 
5 μL 2% BSA, 30 min; 5 μL  0 pg/mL IL-1β or TNF-α (white), 25  pg/mL IL-1β or 10 
μg/mL TNF-α (grey), 60 min; 5 µL 0.5 µg/mL Biotin-anti-IL (c) or Biotin-anti-TNF 
(d); 5 μL 1/500 diluted poly-HRP-Strept  (b) or 1/1000 diluted poly-HRP-Strept (d), 15 
min. 
 
S1.3. Optimization of the blocking step. 
 In order to minimize unspecific adsorptions of immunoreagents on the electrode 
surface, various blocking strategies were evaluated. Various suitable reagents for this 
purpose (1% BSA, 2% BSA, casein, and powder milk) were tested. The protocol 
consisted of adding 5 μL of each blocking solution onto the anti-IL-Phe-
DWCNTs/SPCE or the anti-TNF-Phe-DWCNTs/SPCE allowing incubation for a pre-
established time of 30 min. Then, each immunosensor was prepared in the absence or in 
the presence of 6 µg/mL anti-IL or 4 µg/mL anti-TNF. The results shown in Figure S3a  
revealed a similar behaviour for IL-1β immunosensors using BSA or casein, whereas in 
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the case of TNF-α (Figure S3b), the largest specific-to-unspecific current ratio was 
obtained using 2% BSA. Therefore, this was selected as the blocking agent for further 
work. Moreover, 60 min incubation was selected as it was considered sufficient to 
effectively  minimize unspecific adsorptions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3. Optimization of the blocking step in the preparation of immunosensors for 
IL-1β (a) and TNF-α (b); 3 μL COOH–Phe–DWCNTs; 5 μL Mix&Go, 60 min; 5 μL 6 
µg/mL anti-IL (a) or 4 µg/mL anti-TNF (b), 60 min; 5 μL blocking agent, 30 min;  5 μL 
0 (white) or 250 (grey) pg/mL IL-1β (a), 0 (white) or 250 (grey) pg/mL TNF-α (b), 60 
min; 5 μL 0.5 µg/mL Biotin-anti-IL (a) or Biotin-anti-TNF (b), 60 min; 5 μL 1/2000 
HRP–Strept, 20 min. 
 
S1.4.Optimization of the type and concentration of the HRP-label   
 The effect of different HRP-labels on the response of the immunosensors for IL-
1β and TNF-α was also studied. Figure S3 a and c show the results obtained by using 
HRP-Strept , HRP–Strept–AuNPs, and two poly-HRP-Strept conjugates designed by  
(F) (from Fitzgerald) and (S) (from Sigma). As it was expected, HRP-Strept polymers 
provided a much bigger specific current in both cases because the more elevated 
concentration of enzymes in the label and, subsequently, the higher number of enzymes 
per antigen. As it can also seen, poly-HRP-Strept (F) provided the highest current and 
the best specific-to-unspecific current ratio, and thus, it was selected for further work. 
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 Regarding the effect of the poly-HRP-Strept (F) dilution, Figure S4 b and d 
show a similar behavior for the specific currents with both immunosensors, exhibiting a 
decrease as the concentration of the enzyme label was lower. However, the specific-to-
unspecific current ratio remained practically constant over the whole studied range of 
dilution factors for IL-1β immunosensors whereas slightly increased up to a 1/1000 
dilution for the TNF-α immunosensors. These results led us to select 1/500 dilution of 
poly-HRP-Strept (F) for the preparation of IL-1β and TNF-α  immunosensors.       
 
 
 
Figure S4. Optimization of the type (a,c) and concentration (b,d) of the HRP-label in the 
preparation of immunosensors for IL-1β (a, b) and TNF-α (c, d); 3 μL COOH–Phe–
DWCNTs; 5 μL Mix&Go, 60 min; 5 μL 6 µg/mL anti-IL (a, b) or 4 µg/mL anti-TNF (c, 
d), 60 min; 5 μL blocking agent, 30 min;  5 μL 0 (white) or 25 (grey) pg/mL IL-1β (a, 
c), 0 (white) or 10 (grey) pg/mL TNF-α (c, d), 60 min; 5 μL 0.5 µg/mL Biotin-anti-IL 
(a, b) or Biotin-anti-TNF (c, d), 60 min; 5 μL poly-HRP–Strept (F) (b, d), 20 min. 
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1.5.Storage stability of the immunosensor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S5. Control charts constructed to evaluate the storage stability of  anti-IL-Phe-
DWCNTs/SPCE and anti-TNF-Phe-DWCNTs/SPCE conjugates. Each point 
corresponded to the mean value of three successive measurements for 50 pg/mL IL-1β 
(green) or 100 pg/mL TNF-α (blue).  
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